Akiko Chai

Prosthesis size and long-term survival after aortic valve replacement

Eugene H. Blackstone, Delos M. Cosgrove, W.R. Eric Jamieson et al. · Journal of Thoracic and Cardiovascular Surgery · 2003 · 239 citations · Full text

Medicine, Surgery, Cardiothoracic Surgery +15

A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia

Thomas J. Kipps, Herbert Eradat, Sebastian Grosicki et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 190 citations

Medicine, Pharmacology, Pharmacotherapy +13

Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20⁺ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study

Laurie H. Sehn, André Goy, Fritz Offner et al. · Journal of Clinical Oncology · 2015 · 154 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes

Matthias Pfeifer, Bing Zheng, Tabea Erdmann et al. · Leukemia · 2015 · 152 citations

Pharmacy, Oncology, Pharmacology +10

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

Silvio Danese, Jean‐Frédéric Colombel, Milan Lukáš et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14